|
|
matuzumab A humanized monoclonal antibody with antineoplastic activity. Matuzumab binds the epidermal growth factor receptor (EGFR) with high
affinity, competitively blocking natural ligand binding and
blocking receptor-mediated downstream signalling, resulting in impaired tumor cell proliferation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Code name: | | EMD 72000 | | |
|
|